Funding for this research was provided by:
Clovis Oncology Inc (N/a)
Received: 24 June 2019
Accepted: 18 February 2020
First Online: 14 March 2020
Ethics approval and consent to participate
: Not applicable.
: Patient written informed consent has been obtained. A copy of the consent form is available for review by the Editor of this journal.
: ADS and MN are employees of Clovis Oncology. EP reports a consulting or advisory role for Clovis Oncology; honoraria from Clovis Oncology, Astellas, Bristol-Myers Squibb, and Janssen; and travel support from Clovis Oncology, Astellas, Ipsen, and Janssen.